resiquimod has been researched along with 2019 Novel Coronavirus Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagola, K; Bastian, M; David-Watine, B; Gerards, AL; Hasan, M; Kamp, C; Roßmann, L; Schülke, S; Shorte, SL; Spreitzer, I; Stephen, T; Ullrich, A; van Zandbergen, G; Walber, B | 1 |
| Adams, O; Borkhardt, A; Bulut, O; Debisarun, PA; Domínguez-Andrés, J; Gössling, KL; Kilic, G; Koeken, VACM; Li, Y; Liu, Z; Moorlag, SJCFM; Müller, L; Netea, MG; Oldenburg, M; Ostermann, PN; Rüchel, N; Schaal, H; Struycken, P; Taks, E; Ten Oever, J; van Crevel, R; Xu, CJ; Zhang, B; Zoodsma, M | 1 |
| Anthony, DC; Dunstan, IK; Strekalova, T; Weglinski, CM; Yates, AG; Ying, Y | 1 |
| Chen, H; Chen, X; Deng, F; Gong, W; Huang, K; Hui, X; Jin, M; Sun, X; Tao, YJ; Wang, T; Yang, Y; Zhang, Q; Zhang, S; Zhang, Y; Zhao, Y; Zou, Z | 1 |
4 other study(ies) available for resiquimod and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Distinct single-component adjuvants steer human DC-mediated T-cell polarization via Toll-like receptor signaling toward a potent antiviral immune response.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; COVID-19; Dendritic Cells; Female; Humans; Imidazoles; Immunity, Cellular; Lipid A; Male; Middle Aged; SARS-CoV-2; T-Lymphocytes; Toll-Like Receptors | 2021 |
Induction of trained immunity by influenza vaccination - impact on COVID-19.
Topics: COVID-19; Cross Protection; Cytokines; Down-Regulation; Imidazoles; Immunity, Innate; Incidence; Influenza Vaccines; Netherlands; Personnel, Hospital; Poly I-C; Proteomics; Risk Factors; Sequence Analysis, RNA | 2021 |
Nafamostat reduces systemic inflammation in TLR7-mediated virus-like illness.
Topics: Animals; Benzamidines; COVID-19; COVID-19 Drug Treatment; Guanidines; Illness Behavior; Imidazoles; Inflammation; Male; Mice; Serine Endopeptidases; Serine Proteinase Inhibitors; Toll-Like Receptor 7; Virus Diseases | 2022 |
Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice.
Topics: Adaptation, Physiological; Amino Acid Substitution; Angiotensin-Converting Enzyme 2; Animals; Binding Sites; Caco-2 Cells; Chlorocebus aethiops; COVID-19; Disease Models, Animal; Female; High-Throughput Nucleotide Sequencing; Humans; Imidazoles; Mice; Mice, Inbred BALB C; SARS-CoV-2; Serial Passage; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Replication; Whole Genome Sequencing | 2021 |